Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06519487 · ClinicalTrials.gov registry record · NA
Social Experiences and Demographic Factors in the Regulation of Immune Cells
A NA study of Inflammatory Response and RNA, sponsored by Morgan State University.
- Recruiting
- Registry status
- NA
- Development phase
- 480
- Enrollment target
- 2
- Study locations
NCT06519487: Recruiting NA study of Inflammatory Response and RNA, sponsored by Morgan State University.
NCT06519487 is a NA study of Inflammatory Response and RNA that is actively recruiting participants, run by Morgan State University. The registered enrollment target is 480 participants, above the 148-participant average among 16 other Inflammatory Response trials with a reported enrollment target (224% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06519487, a NA study of Inflammatory Response and RNA, is actively recruiting participants, sponsored by Morgan State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 480 participants
- Enrollment target
- 2
- Study locations
Study Summary
Immune-mediated inflammatory diseases are a health burden for approximately seven percent of the population of Western nations. Preliminary data suggest variations in ethnic identity and/or geography influence discrimination experiences and inflammatory response trends. This study investigates how geography, ethnicity, and laboratory manipulation of discrimination experiences affect immune cell function and genomic regulation. Flow cytometry and immune cell stimulation will test monocytes collected from peripheral blood for functional effects. Next-generation transcriptomics and epigenomics will assess genomic and epigenetic mechanisms. The hypothesis is that geography, self-identified race, and ethnicity, interacting with laboratory discrimination conditions during the virtual ballgame Cyberball™, significantly affect immune cell function through genomic and epigenetic mechanisms, with perceived discrimination as a moderating factor on the immune outcomes. The transdisciplinary nature of the proposed study aims to provide valuable insights into differential susceptibility to immune-mediated inflammatory diseases across diverse populations. Uncovering these insights will better inform population-relevant interventions for immune-mediated inflammatory diseases.
Conditions Studied
Interventions
- BEHAVIORAL Cyberball
Study Locations (2)
Maryland
- Morgan State University - Baltimore
Texas
- Texas Christian University - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2025-02-03 |
| Est. Completion | 2029-02-28 |
| Phase | NA |
What NCT06519487 shows while recruiting
NCT06519487 is an interventional study that assigns participants to a tested intervention. The registered 480 participants enrollment target is mid-sized for trials with a published cap, above the 148-participant average among 16 other Inflammatory Response trials with a reported enrollment target (224% higher).
The record links to 3 conditions, with Inflammatory Response appearing as the primary indexed condition, and to 1 intervention - of which Cyberball is the first listed.
NCT06519487 reports a single indexed study location in Maryland, Texas.
Frequently Asked Questions
What is clinical trial NCT06519487 about?
NCT06519487 is a clinical study titled "Social Experiences and Demographic Factors in the Regulation of Immune Cells". Immune-mediated inflammatory diseases are a health burden for approximately seven percent of the population of Western nations. Preliminary data suggest variations in ethnic identity and/or geography influence discrimination experiences and inflammatory response trends. This study investigates how g...
What is the current status of trial NCT06519487?
This trial is currently recruiting. It is a NA study. The enrollment target is 480 participants. The study started on 2025-02-03. Estimated completion is 2029-02-28.
What conditions does trial NCT06519487 study?
This clinical trial studies the following conditions: Inflammatory Response, RNA, Perceived Discrimination.
What interventions are being tested in trial NCT06519487?
The interventions under investigation include: Cyberball (BEHAVIORAL).
Who is sponsoring clinical trial NCT06519487?
This trial is sponsored by Morgan State University, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06519487 being conducted?
This trial has 2 study locations across Maryland, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammatory Response
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06519487's enrollment target sits among peer trials
480 2nd of 16 the highest of 16 other Inflammatory Response trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inflammatory Response trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Menthol, Inflammation, and Nicotine Transition Study
RECRUITING · NA
-
Examining the Role of Female Endogenous Sex Hormones in Eccentric Exercise
RECRUITING · NA
-
Association Between Body Composition and Pain in Spinal Cord Injury
RECRUITING · NA
-
Daoist Zhanzhuang and Human Flourishing
RECRUITING · NA
-
Investigating Age-dependent Effects of Egg Intake on HDL and Immune Profiles
ACTIVE NOT RECRUITING · NA
-
Beef and Plant Burger Metabolomics Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01954992 · 480 participants · Phase 3
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
- NCT03023696 · 480 participants · NA
Can Prophylactic Foraminotomy Prevent C5 Palsy
- NCT04948060 · 480 participants · NA
Tribally Engaged Approaches to Lung Screening (TEALS)
- NCT05053230 · 480 participants · NA
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI